Is Nanotechnology an Industry or a Technology? How do investors perform due diligence of nanotechnology patent portfolios? What is the difference between the valuation and evaluation of IP in this emerging field? These, and many other questions, were discussed at the High-Tech Sector’s Nanotechnology mini-plenary session at the LES Winter Meeting in Anaheim (March 13, 2012). This dynamic session was moderated by Luca Escoffier, CEO of Usque Ad Sidera LLC, entrepreneur, author, and international technology transfer expert. The multi-disciplinary panel included: Sarah Rouse, patent attorney with Katten Muchin Rosenman, LLP, whose legal practice is focused on nanotechnology and materials engineering; Ken Epstein, Principal of NewCap Partners, Inc., specializing in advanced materials and cleantech investment, and formerly Dow Chemical’s corporate ventures manager for nanotechnology products; Lance Criscuolo, President of Zyvex Technologies, one of the first companies to successfully commercialize materials that take advantage of carbon nanotubes; and Efrat Kasznik, President of Foresight Valuation Group LLC, an expert in intellectual property valuation and strategy, and a lecturer at the Stanford Graduate School of Business.

Seminar Information
Seminar Date:
April 17, 2012
Beyond Asbestos and Patent Thickets: The Path to Successfully Commercializing Nanotechnology IP
Individual topic purchase: Selected
Online Materials
LES Member Price:$0.00
Non-Member Price:$0.00